Ann: Proposed BioHealth Acquisition , page-8

I agree. Marketing is a good way for pushing products that have no lab tested proof. So the brand power will be important.

I'm a believer of the saying: good management makes good companies. In Acuvax, we have most of the directors having investment backgrounds. You'd expect directors with good lab/chemical engineering experience would be ideal. But thinking optimistically:

-We now have a product to invest in
-We have investment/mining/accounting/resourcing background directors. These industries sectors rely alot on brand power for people to invest in them or purpose their products.
-Referring to the above, hopefully these guys know how to make a sale!

Looking at it negatively:
-directors do not have any experience selling pharmaceutical products.
-given enough sales do take place as a result of a general interest (ie not high to cause a company maker, not low enough to cause bankruptcy); share price does not move...like the most of this year.


I remain optimistic with my small holding in acu. Small holding, but big gain %'s if ANYTHING ever happens in this quiet neighborhood...